AstraZeneca Pharma India moves Delhi High Court against NPPA demand notice June 29, 2021 Auto Bot News 0 The notice of demand alleges that the company has overcharged about Rs 157.38 crore during the period from March 8, 2019 to January 31, 2021 in respect of Tagrisso (Osimertinib) 80 mg tablets.